Participant Protection in Phase 1 Pediatric Cancer Trials

This Viewpoint describes changes in the regulatory environment for phase 1 research involving children and discusses improvements to patient protection.

Read the full article here

Related Articles

Trauma-Informed Care

This JAMA Insights discusses trauma-informed care practices that can help clinicians provide sensitive and supportive care that may improve health outcomes in patients with a…